Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
급성 후 COVID-19는 염증성 장 질환에서 장 바이러스 항원 지속성을 특징으로 합니다
Article
[키워드] acute COVID-19
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
affected
Antigen
biochemical
CD8
Chain Reaction
clinical trials
Confirmed COVID-19 infection
controlled clinical trials
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 infection
Culture
detectable
endoscopy
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluated
expression of SARS-CoV-2
flow cytometry
globe
Gut
gut mucosa
IBD
immune
immune response
immunofluorescence
immunosuppressive
immunosuppressive therapy
Inflammation
Inflammatory bowel disease
intestine
investigated
large intestine
majority
means
Mild
nucleocapsid
nucleocapsid protein
pandemic
Patient
performed
persistence
polymerase chain
polymerase chain reaction
populations
Postacute COVID-19
Quantitative
quantitative polymerase chain reaction
questionnaire
reported
RNA
SARS-CoV-2
SARS-CoV-2 antigen
SARS-CoV-2 antigens
SARS-CoV-2 RNA
severe acute respiratory syndrome Coronavirus
severity
Stool
syndrome
T cells
therapy
tissue
Viral antigen
Viral Antigen Persistence.
viral nucleocapsid protein
viral transcripts
virus cultivation
[DOI] 10.1053/j.gastro.2022.04.037 PMC 바로가기 [Article Type] Article
[DOI] 10.1053/j.gastro.2022.04.037 PMC 바로가기 [Article Type] Article